2-((2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy) ethyl monophosphate

ID: ALA575202

Chembl Id: CHEMBL575202

PubChem CID: 45481630

Max Phase: Preclinical

Molecular Formula: C7H11N2O7P

Molecular Weight: 266.15

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1ccn(COCCOP(=O)(O)O)c(=O)[nH]1

Standard InChI:  InChI=1S/C7H11N2O7P/c10-6-1-2-9(7(11)8-6)5-15-3-4-16-17(12,13)14/h1-2H,3-5H2,(H,8,10,11)(H2,12,13,14)

Standard InChI Key:  QQXODIYVVBVZDS-UHFFFAOYSA-N

Alternative Forms

  1. Alternative Forms:

    ALA575202

    ---

Associated Targets(non-human)

P2ry2 Purinergic receptor P2Y2 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.15Molecular Weight (Monoisotopic): 266.0304AlogP: -1.38#Rotatable Bonds: 6
Polar Surface Area: 130.85Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 1.21CX Basic pKa: CX LogP: -1.38CX LogD: -4.93
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.43Np Likeness Score: 0.03

References

1. Sauer R, El-Tayeb A, Kaulich M, Müller CE..  (2009)  Synthesis of uracil nucleotide analogs with a modified, acyclic ribose moiety as P2Y(2) receptor antagonists.,  17  (14): [PMID:19523835] [10.1016/j.bmc.2009.05.062]

Source